Highlights
The global Small Molecule Targeted Therapy market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Small Molecule Targeted Therapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Small Molecule Targeted Therapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Small Molecule Targeted Therapy in Liver Cancer is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Small Molecule Targeted Therapy include Astrazeneca, Novartis, Millennium Pharmaceuticals, Bayer, Exelixis, Abbvie, Boehringer-Ingelheim, Eisai and Pfizer, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Small Molecule Targeted Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Targeted Therapy.
The Small Molecule Targeted Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Small Molecule Targeted Therapy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule Targeted Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Astrazeneca
Novartis
Millennium Pharmaceuticals
Bayer
Exelixis
Abbvie
Boehringer-Ingelheim
Eisai
Pfizer
Bristol-Myers Squibb
Roche
Bettapharma
Segment by Type
TKI
Multitarget Inhibitor
Others
Segment by Application
Liver Cancer
Colorectal Cancer
Lung Cancer
Gastric Cancer
Breast Cancer
Esophageal Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule Targeted Therapy companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Targeted Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 TKI
1.2.3 Multitarget Inhibitor
1.2.4 Others
1.3 Market by Application
1.3.1 Global Small Molecule Targeted Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Liver Cancer
1.3.3 Colorectal Cancer
1.3.4 Lung Cancer
1.3.5 Gastric Cancer
1.3.6 Breast Cancer
1.3.7 Esophageal Cancer
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Targeted Therapy Market Perspective (2018-2029)
2.2 Small Molecule Targeted Therapy Growth Trends by Region
2.2.1 Global Small Molecule Targeted Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Small Molecule Targeted Therapy Historic Market Size by Region (2018-2023)
2.2.3 Small Molecule Targeted Therapy Forecasted Market Size by Region (2024-2029)
2.3 Small Molecule Targeted Therapy Market Dynamics
2.3.1 Small Molecule Targeted Therapy Industry Trends
2.3.2 Small Molecule Targeted Therapy Market Drivers
2.3.3 Small Molecule Targeted Therapy Market Challenges
2.3.4 Small Molecule Targeted Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Targeted Therapy Players by Revenue
3.1.1 Global Top Small Molecule Targeted Therapy Players by Revenue (2018-2023)
3.1.2 Global Small Molecule Targeted Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Small Molecule Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Small Molecule Targeted Therapy Revenue
3.4 Global Small Molecule Targeted Therapy Market Concentration Ratio
3.4.1 Global Small Molecule Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Targeted Therapy Revenue in 2022
3.5 Small Molecule Targeted Therapy Key Players Head office and Area Served
3.6 Key Players Small Molecule Targeted Therapy Product Solution and Service
3.7 Date of Enter into Small Molecule Targeted Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Targeted Therapy Breakdown Data by Type
4.1 Global Small Molecule Targeted Therapy Historic Market Size by Type (2018-2023)
4.2 Global Small Molecule Targeted Therapy Forecasted Market Size by Type (2024-2029)
5 Small Molecule Targeted Therapy Breakdown Data by Application
5.1 Global Small Molecule Targeted Therapy Historic Market Size by Application (2018-2023)
5.2 Global Small Molecule Targeted Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Small Molecule Targeted Therapy Market Size (2018-2029)
6.2 North America Small Molecule Targeted Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Small Molecule Targeted Therapy Market Size by Country (2018-2023)
6.4 North America Small Molecule Targeted Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule Targeted Therapy Market Size (2018-2029)
7.2 Europe Small Molecule Targeted Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Small Molecule Targeted Therapy Market Size by Country (2018-2023)
7.4 Europe Small Molecule Targeted Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Targeted Therapy Market Size (2018-2029)
8.2 Asia-Pacific Small Molecule Targeted Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Small Molecule Targeted Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Small Molecule Targeted Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Molecule Targeted Therapy Market Size (2018-2029)
9.2 Latin America Small Molecule Targeted Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Small Molecule Targeted Therapy Market Size by Country (2018-2023)
9.4 Latin America Small Molecule Targeted Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Targeted Therapy Market Size (2018-2029)
10.2 Middle East & Africa Small Molecule Targeted Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Small Molecule Targeted Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Small Molecule Targeted Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astrazeneca
11.1.1 Astrazeneca Company Detail
11.1.2 Astrazeneca Business Overview
11.1.3 Astrazeneca Small Molecule Targeted Therapy Introduction
11.1.4 Astrazeneca Revenue in Small Molecule Targeted Therapy Business (2018-2023)
11.1.5 Astrazeneca Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Small Molecule Targeted Therapy Introduction
11.2.4 Novartis Revenue in Small Molecule Targeted Therapy Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Millennium Pharmaceuticals
11.3.1 Millennium Pharmaceuticals Company Detail
11.3.2 Millennium Pharmaceuticals Business Overview
11.3.3 Millennium Pharmaceuticals Small Molecule Targeted Therapy Introduction
11.3.4 Millennium Pharmaceuticals Revenue in Small Molecule Targeted Therapy Business (2018-2023)
11.3.5 Millennium Pharmaceuticals Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Small Molecule Targeted Therapy Introduction
11.4.4 Bayer Revenue in Small Molecule Targeted Therapy Business (2018-2023)
11.4.5 Bayer Recent Development
11.5 Exelixis
11.5.1 Exelixis Company Detail
11.5.2 Exelixis Business Overview
11.5.3 Exelixis Small Molecule Targeted Therapy Introduction
11.5.4 Exelixis Revenue in Small Molecule Targeted Therapy Business (2018-2023)
11.5.5 Exelixis Recent Development
11.6 Abbvie
11.6.1 Abbvie Company Detail
11.6.2 Abbvie Business Overview
11.6.3 Abbvie Small Molecule Targeted Therapy Introduction
11.6.4 Abbvie Revenue in Small Molecule Targeted Therapy Business (2018-2023)
11.6.5 Abbvie Recent Development
11.7 Boehringer-Ingelheim
11.7.1 Boehringer-Ingelheim Company Detail
11.7.2 Boehringer-Ingelheim Business Overview
11.7.3 Boehringer-Ingelheim Small Molecule Targeted Therapy Introduction
11.7.4 Boehringer-Ingelheim Revenue in Small Molecule Targeted Therapy Business (2018-2023)
11.7.5 Boehringer-Ingelheim Recent Development
11.8 Eisai
11.8.1 Eisai Company Detail
11.8.2 Eisai Business Overview
11.8.3 Eisai Small Molecule Targeted Therapy Introduction
11.8.4 Eisai Revenue in Small Molecule Targeted Therapy Business (2018-2023)
11.8.5 Eisai Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Small Molecule Targeted Therapy Introduction
11.9.4 Pfizer Revenue in Small Molecule Targeted Therapy Business (2018-2023)
11.9.5 Pfizer Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Detail
11.10.2 Bristol-Myers Squibb Business Overview
11.10.3 Bristol-Myers Squibb Small Molecule Targeted Therapy Introduction
11.10.4 Bristol-Myers Squibb Revenue in Small Molecule Targeted Therapy Business (2018-2023)
11.10.5 Bristol-Myers Squibb Recent Development
11.11 Roche
11.11.1 Roche Company Detail
11.11.2 Roche Business Overview
11.11.3 Roche Small Molecule Targeted Therapy Introduction
11.11.4 Roche Revenue in Small Molecule Targeted Therapy Business (2018-2023)
11.11.5 Roche Recent Development
11.12 Bettapharma
11.12.1 Bettapharma Company Detail
11.12.2 Bettapharma Business Overview
11.12.3 Bettapharma Small Molecule Targeted Therapy Introduction
11.12.4 Bettapharma Revenue in Small Molecule Targeted Therapy Business (2018-2023)
11.12.5 Bettapharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Astrazeneca
Novartis
Millennium Pharmaceuticals
Bayer
Exelixis
Abbvie
Boehringer-Ingelheim
Eisai
Pfizer
Bristol-Myers Squibb
Roche
Bettapharma
听
听
*If Applicable.
